Deviation – Pharma.Tips

Personnel not trained on revised SOP during deviation investigation – QMS remediation failure

Case Study: Addressing Training Gaps in SOP Compliance During Deviation Investigations In the complex environment of pharmaceutical manufacturing, the risk of compliance failures can often stem from seemingly minor lapses…

Media fill deviation not escalated during cleaning verification – containment CAPA failure

“`html Case Study on Unmanaged Media Fill Deviation During Cleaning Verification The pharmaceutical manufacturing industry is highly regulated, where even minor deviations can have significant consequences on product quality and…

Personnel not trained on revised SOP during audit – QMS remediation failure

Case Study: Addressing Personnel Training Gaps on Revised SOPs During Audit In the highly regulated pharmaceutical industry, adherence to standard operating procedures (SOPs) is critical for maintaining quality and compliance.…

Document revisions uncontrolled during deviation investigation – QMS remediation failure

Uncontrolled Document Revisions During a Deviation Investigation: A Quality Management System Remediation Case Study In the high-stakes world of pharmaceutical manufacturing, the integrity of documentation is non-negotiable. This case study…

GDP errors repeated during audit – inspection citation risk explained

Understanding and Managing Repeated GDP Errors During Regulatory Audits In the highly regulated pharmaceutical environment, the accuracy and integrity of Good Distribution Practice (GDP) are crucial for maintaining compliance with…

Training effectiveness not assessed during audit – inspection citation risk explained

Understanding Inspection Risks Due to Unassessed Training Effectiveness In a typical pharmaceutical manufacturing environment, the compliance with Good Manufacturing Practices (GMP) goes beyond just adhering to technical standards. During a…

Backdated training evidence during audit – inspection citation risk explained

Understanding Risks of Backdated Training Evidence in Pharmaceutical Audits In the realm of pharmaceutical manufacturing and quality assurance, the credibility of training documentation is critical. An incident involving backdated training…

Personnel not trained on revised SOP during inspection – QMS remediation failure

Case Study: Addressing Personnel Training Gaps During Regulatory Inspections In the pharmaceutical industry, adherence to Standard Operating Procedures (SOPs) is not just a regulatory requirement but a critical component of…

Personnel not trained on revised SOP during audit – inspection citation risk explained

Understanding the Risks of Untrained Personnel on Revised SOPs During Regulatory Audits In a recent inspection at a sterile development and manufacturing facility, the FDA cited a significant deficiency related…

Training effectiveness not assessed during inspection – CAPA and training system breakdown

Assessing the Impact of Untested Training Effectiveness on Compliance: A Case Study In the complex world of pharmaceutical manufacturing, ensuring that all personnel are adequately trained is not merely a…

Backdated training evidence during QA review – CAPA and training system breakdown

Investigation of Backdated Training Evidence During QA Review: A Case Study In pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) is paramount, especially when it comes to training and documentation.…

Document revisions uncontrolled during inspection – CAPA and training system breakdown

Management of Uncontrolled Document Revisions During Regulatory Inspections In pharmaceutical manufacturing, the integrity and control of documentation are paramount. A case study from a mid-sized European pharmaceutical company highlights the…